Literature DB >> 15472178

Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo.

Judith L Ross1, David E Sandberg, Susan R Rose, Ellen Werber Leschek, Jeffrey Baron, John J Chipman, Fernando G Cassorla, Charmian A Quigley, Brenda J Crowe, Kristen Roberts, Gordon B Cutler.   

Abstract

The influence of short stature on psychological adaptation in childhood and adolescence is controversial. GH is currently used to treat children with idiopathic short stature (ISS, also known as non-GH-deficient short stature). This study represents the first double-blind, placebo-controlled trial of the effects of GH on the psychological adaptation of children and adolescents with ISS, treated with GH until adult height was attained.Sixty-eight children (53 males, 15 females), 9-16 yr old, with marked ISS (measured height or predicted adult height -2.5 sd or less) received either GH 0.074 mg/kg or placebo sc three times per week until height velocity decreased to less than 1.5 cm/yr. Parents completed the Child Behavior Checklist (CBCL) and children the Self-Perception Profile (SPP) and Silhouette Apperception Technique at baseline and annually thereafter. Baseline behavioral/emotional adjustment (CBCL) and self-concept (SPP) scores for children with ISS were within the normative range. The two study groups exhibited similar behavioral and self-concept profiles (CBCL) during the first 2 yr of the study. However, CBCL behavior problems (internalizing, externalizing, and total problems) appeared to decline, in yr 3 and 4, in the GH-treated group relative to the placebo-treated group. Group differences in CBCL competency domains and the SPP were not observed at any point during the study. Short stature among children with ISS enrolled in this long-term, placebo-controlled study was not associated with problems in psychological adaptation or self-concept with the psychological instruments employed. GH treatment was associated with a trend toward improvement in problem behaviors, as measured by questionnaires (CBCL) completed by study participants' parents. It remains to be determined whether GH treatment significantly impacts adaptation, psychosocial function, or quality of life in children with ISS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472178     DOI: 10.1210/jc.2004-0791

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  22 in total

Review 1.  Growing up with idiopathic short stature: psychosocial development and hormone treatment; a critical review.

Authors:  H Visser-van Balen; G Sinnema; R Geenen
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

Review 2.  Dilemmas of growth hormone treatment for GH deficiency and idiopathic short stature: defining, distinguishing, and deciding.

Authors:  Julia G Halas; Adda Grimberg
Journal:  Minerva Pediatr       Date:  2020-04-09       Impact factor: 1.312

3.  Growth patterns and the use of growth hormone in the mucopolysaccharidoses.

Authors:  L E Polgreen; B S Miller
Journal:  J Pediatr Rehabil Med       Date:  2010

4.  Understanding the impact of statural height on health-related quality of life in German adolescents: a population-based analysis.

Authors:  Rachel Sommer; Anne Daubmann; Julia Quitmann; Ulrike Ravens-Sieberer; Monika Bullinger
Journal:  Eur J Pediatr       Date:  2014-12-24       Impact factor: 3.183

5.  Health-related quality of life and cognitive functioning in pediatric short stature: comparison of growth-hormone-naïve, growth-hormone-treated, and healthy samples.

Authors:  Matthew D Stephen; James W Varni; Christine A Limbers; Michael Yafi; Rubina A Heptulla; Venkat S Renukuntla; Cynthia S Bell; Patrick G Brosnan
Journal:  Eur J Pediatr       Date:  2010-10-01       Impact factor: 3.183

6.  Are rates of functional limitations associated with access to care? A state-level analysis of the national survey of children with special health care needs.

Authors:  Ruth E K Stein; Ellen Johnson Silver
Journal:  Matern Child Health J       Date:  2005-06

Review 7.  Clinical practice. Short stature in childhood--challenges and choices.

Authors:  David B Allen; Leona Cuttler
Journal:  N Engl J Med       Date:  2013-03-28       Impact factor: 91.245

8.  Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Authors:  J Paul Frindik; Stephen F Kemp
Journal:  Biologics       Date:  2010-06-24

Review 9.  Treatment of children and adolescents with idiopathic short stature.

Authors:  Michael B Ranke
Journal:  Nat Rev Endocrinol       Date:  2013-04-23       Impact factor: 43.330

10.  Idiopathic short stature: conundrums of definition and treatment.

Authors:  Arlan L Rosenbloom
Journal:  Int J Pediatr Endocrinol       Date:  2009-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.